omicron | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
September 04, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, SEPTEMBER 04, 2025

omicron

omicron

Omicron subvariant XBB.1: An illustration of the novel coronavirus seen next to a health care worker at a Covid-19 testing centre in New Delhi. (Sanchit Khanna / HT Photo)

Omicron subvariant XBB.1.5 may be dominant in Europe soon: Health agency

XBB.1.5 In Europe: The health body said that the risk associated with the subvariant was estimated to be low.

File Photo: Reuters

'Covid cases still low but no alternative to caution'

FILE PHOTO: Chinese President Xi Jinping looks on during a meeting with Thai Prime Minister Prayuth Chan-ocha on the sidelines of the Asia-Pacific Economic Cooperation (APEC) summit in Bangkok, Thailand November 19, 2022. REUTERS/Athit Perawongmetha/Pool/File Photo

China's Xi told EU less lethal Omicron opens way for fewer Covid restrictions

(Reuters file image)

New Omicron sub-variant ‘XBB’ detected in Bangladesh

Omicron subvariant XBB.1: An illustration of the novel coronavirus seen next to a health care worker at a Covid-19 testing centre in New Delhi. (Sanchit Khanna / HT Photo)

New Omicron subvariant XBB.1 is ‘strongest by far in vaccine evasion’: Report

A health worker prepares a booster dose of a coronavirus disease (Covid-19) vaccine, as vaccinations jump in Italy after the government made inoculation mandatory for all workers, in Rome, Italy. Photo: Reuters

White House urges Covid boosters to protect against spreading BA.5 subvariant

(Reuters file image)

Australia expands fourth Covid dose rollout amid fresh Omicron threat

Photo: Collected

US medical experts call for Omicron-specific Covid boosters

Illustration: Collected

Omicron sub variant dominant in Bangladesh since May : Report

FILE PHOTO: A vial labelled "Sinopharm COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration

Some Omicron sub-variants escaping antibodies from Sinopharm shot

(Reuters file image)

Early Omicron infection unlikely to protect against current variants

(Reuters file image)

Early Omicron infection unlikely to protect against current variants

India's active case count now stands at 3.90 per cent. ( HT file Photo)

Omicron less likely to cause long COVID - UK study

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net